MedPath

Vemlidy

Brand Name: Vemlidy

Generic Name: Tenofovir alafenamide (as fumarate)

Active
Registration Number

DR-XY46540

Dosage Form

Film-Coated Tablet

Issuance Date

July 31, 2024

Expiry Date

March 28, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength25 mg
PackagingWhite HDPE Bottle Sealed with Polypropylene Child- Resistant Cap, lined with an Aluminum Foil Seal Liner containing Silica Gel Dessicant and Polyester Coil. (Box of 30's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Direct Acting Antiviral (Nucleoside and Nucleotide Reverse Transcriptase Inhibitor)
A
Application
Initial (from Monitored Release)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Tenofovir alafenamide (as fumarate)Active
Monograph: tenofovir alafenamide (as fumarate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform